| Pictilisib |
GDC-0941 |
957054-30-7 |
| 3-BROMO-5-CHLOROPYRAZOLO[1,5-A]PYRIMIDINE |
3-溴-5-氯吡唑[1,5-A]并嘧啶 |
960613-96-1 |
| 6,8-dibromo-[1,2,4]triazolo[1,5-a]pyrazine |
6,8-二溴-[1,2,4]噻唑并[1,5-A]吡嗪 |
944709-42-6 |
| N-[3-[4,5-Dihydro-4-methyl-6-[[4-(4-morpholinylcarbonyl)phenyl]amino]-5-oxo-2-pyrazinyl]-2-methylphenyl]-4-(tert-butyl)benzamide |
N-[3-[4,5-二氢-4-甲基-6-[[4-(4-吗啉基羰基)苯基]氨基]-5-氧代-2-吡嗪基]-2-甲基苯基]-4-(叔丁基)苯甲酰胺 |
910232-84-7 |
| NVP-BGJ398 |
FGFR抑制剂(NVP-BGJ398) |
872511-34-7 |
| Neratinib |
来那替尼 |
698387-09-6 |
| N-(2,3-Dihydro-7,8-dimethoxyimidazo[1,2-c]quinazolin-5-yl)-3-pyridinecarboxamide |
N-(2,3-二氢-7,8-二甲氧基咪唑并[1,2-C]喹唑啉-5-基)-3-吡啶甲酰胺 |
677338-12-4 |
| Vandetanib |
凡德他尼 |
443913-73-3 |
| 6-Amino-N-[3-[4-(4-morpholinyl)pyrido[3',2':4,5]furo[3,2-d]pyrimidin-2-yl]phenyl]-3-pyridinecarboxamide |
6-氨基-N-[3-[4-(4-吗啉基)吡啶并[3',2':4,5]呋喃并[3,2-D]嘧啶-2-基]苯基]-3-吡啶甲酰胺 |
371942-69-7 |
| Furo[2,3-b]pyridine-2-carboxylic acid, 3-amino-, ethyl ester (9CI) |
3-氨基-呋喃并[2,3-B]嘧啶-2-甲酸乙酯 |
371945-06-1 |
| PD 0325901 |
N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2-[(2-氟-4-碘苯)氨基]苯甲酰胺 |
391210-10-9 |
| 3-[N-(2-Hydroxyacetyl)-4-piperidyl]-4-(4-pyrimidinyl)-5-(4-chlorophenyl)pyrazole |
3-[N-(2-羟基乙酰基)-4-哌啶基]-4-(4-嘧啶基)-5-(4-氯苯基)吡唑 |
271576-80-8 |
| 5-(4-aMino-1-isopropyl-1H-pyrazolo[3,4-d]pyriMidin-3-yl)benzo[d]oxazol-2-aMine |
3-(2-氨基-5-苯并恶唑基)-1-(1-甲基乙基)-1H-吡唑并[3,4-D]嘧啶-4-胺 |
1224844-38-5 |
| NVP-BSK805 |
NVP-BSK805 dihydrochloride |
1092499-93-8 |
| (S)-1-[4-[[2-(2-Aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one |
(S)-1-[4-[[2-(2-氨基嘧啶-5-基)-7-甲基-4-(吗啉-4-基)噻吩并[3,2-D]嘧啶-6-基]甲基]哌嗪-1-基]-2-羟基丙-1-酮 |
1032754-93-0 |
| SB 203580 |
4-(4-氟苯基)-2-(4-甲基亚磺酰基苯基)-5-(4-吡啶基)-1H-咪唑 |
152121-47-6 |
| PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXYLIC ACID ETHYL ESTER |
吡唑并[1,5-A]嘧啶-3-羧酸乙酯 |
115932-00-8 |
| Foretinib (GSK1363089) |
N-[3-氟-4-[[6-甲氧基-7-[[3-(吗啉-4-基)丙基]氧]喹啉-4-基]氧]苯基]-N'-(4-氟苯基)环丙烷-1,1-二甲酰胺 |
849217-64-7 |
